Emily Glazer

because the Food and Drug Administration prohibits reviewing applications for human trials that involve embryo editing.

What we've actually seen more recently is that Preventive has hired more scientists.

On LinkedIn, we saw someone else started there in January 2026, listed as a senior scientist.

Another person started in December 2025.

That company is growing since we reported on it.

A bunch of new startups are claiming that they can help prospective parents be able to choose more traits with the embryos that they create.

Some offer eye color, baldness.

It's not just cosmetic.

There's also more screening for different diseases beyond what you could traditionally get.

Absolutely.

I think that's a big question, right?

Who's going to be that person to say, why wouldn't you want to help eradicate diseases?

And I think you'd be hard-pressed to find someone who doesn't have some kind of personal connection to someone somewhere who knows someone who died from a genetic disease.

And if you said, I can help cure this, who's going to say no to that?

How could there not be?

Yeah, I mean, if you take a step back, it's almost like comparing the perhaps lowercase c conservative nature of academia to the other extreme of tech entrepreneurs.

One group wants to study every last thing and the other one wants to rip off the band-aid and start doing it.

Just try it and see what happens and then learn from your mistakes.

Ask for forgiveness later.

You know, Elon Musk sends rockets up in space and he'll do it quickly and the rocket might blow up, but then he'll learn from them.